This cluster reflects routine option exercises and modest share sales for tax and personal liquidity purposes, not a signal of fundamental concern. Monitor for any acceleration in open-market selling, but current activity is within normal range for executives managing equity compensation.
Price Chart
Executive Summary
United Therapeutics CEO Martine Rothblatt and EVP Paul Mahon exercised stock options and sold shares in the open market, generating over $3.7 million in proceeds. The activity is part of a routine stock option exercise and partial sale of shares, not an outright open-market sell-off of owned shares. Director Judy Olian also sold a small portion of her holdings.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt exercised options for 38,000 shares (across multiple tranches) at $146.03 and $0 strike prices, with total intrinsic value of $4.17 million.
- Rothblatt sold 679 shares in open-market transactions totaling $356,253 in proceeds.
- EVP Paul Mahon exercised options for 16,600 shares at $146.03, with intrinsic value of $2.42 million, and sold 753 shares for $397,184.
- Director Judy Olian sold 200 shares for $106,000 in an open-market transaction.
- Total open-market sales by insiders: $859,437 over 7 days, consistent with recent 30-day trend of $839K in sales.
- Non-cash transactions (option exercises at $0) are administrative and do not reflect economic activity.
Financial Impact
$859,437 in open-market sales over 7 days; total derivative exercises valued at $6.59 million (non-cash). Total insider selling represents 0.0038% of $22.8B market cap.
Risk Factors
- Perception risk if media or investors misinterpret option exercises and related sales as negative sentiment.
- Minor dilution from exercised options, though negligible relative to company size.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (13 trades, 7d window) | cluster-UTHR-1774384344570 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $552.73 (+10.47%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $552.73 (+11.19%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $552.73 (+9.70%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $552.73 (+9.06%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $552.73 (+13.36%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $552.73 (+13.23%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $552.73 (+7.23%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $552.73 (+4.70%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $552.73 (+6.98%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $552.73 (+6.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access